MechanismsAnimals

A protein mutation curbs brain damage in mice with dementia

Young and 18-month-old mice with an altered UCHL1 protein showed less white matter injury and better sensorimotor and cognitive performance in a dementia model.

Figure 1 from Scientific Reports
Open the figure at full size
Figure 1Mi et al. · CC BY-NC-ND

Scientific Reports

In an experiment in young and 18-month-old mice, researchers tested whether mutating a specific protein could reduce brain damage in vascular cognitive impairment and dementia. The condition is characterized by extensive subcortical white matter injury and progressive sensorimotor and cognitive impairment.

The researchers produced an experimental model of the disorder, called asymmetric bilateral common carotid artery stenosis, in mice bearing a UCHL1 cysteine 152 to alanine mutation and in wild-type controls.

Mice with the mutation exhibited reduced white matter injury as detected by diffusion tensor brain imaging in both age groups. Mutated mice also showed improved performance compared to controls on tests of sensorimotor function, water maze navigation, passive avoidance, and novel object recognition.

Why it matters

Because the researchers tested 18-month-old mice alongside young adults, the findings bear on whether targeting the UCHL1 protein could help protect nerve tissue and preserve cognitive function when blood flow is compromised in older brains.

Caveats

The study relied on an induced mouse model of carotid artery stenosis, which may not capture all features of human vascular cognitive impairment and dementia. Furthermore, the animals carried the genetic mutation from the start rather than receiving a treatment after injury had occurred.

The paper

Mutating ubiquitin carboxy terminal hydrolase L1 cysteine 152 ameliorates white matter injury and functional deficits in experimental vascular dementia